SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Phaarmasia - Quaterly Results

14 Aug 2023 Evaluate
The sales moved up 27.81% to Rs. 68.75 millions for the June 2023 quarter as compared to Rs. 53.79 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -2.65 millions as compared to Net Loss of Rs. -2.84 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 improved to -1.76% as compared to -2.06% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 68.75 53.79 27.81 68.75 53.79 27.81 274.90 172.16 59.68
Other Income 1.44 1.26 14.29 1.44 1.26 14.29 5.16 4.70 9.79
PBIDT -1.76 -2.06 -14.56 -1.76 -2.06 -14.56 -10.27 -12.65 -18.81
Interest 0.08 0.01 700.00 0.08 0.01 700.00 0.45 0.04 1025.00
PBDT -1.84 -2.07 -11.11 -1.84 -2.07 -11.11 -10.72 -12.69 -15.52
Depreciation 0.85 0.63 34.92 0.85 0.63 34.92 3.60 2.92 23.29
PBT -2.69 -2.70 -0.37 -2.69 -2.70 -0.37 -14.32 -15.61 -8.26
TAX -0.04 0.14 -128.57 -0.04 0.14 -128.57 -1.73 -0.15 1053.33
Deferred Tax -0.04 0.14 -128.57 -0.04 0.14 -128.57 -1.73 -0.15 1053.33
PAT -2.65 -2.84 -6.69 -2.65 -2.84 -6.69 -12.59 -15.46 -18.56
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) -2.56 -3.83 -33.15 -2.56 -3.83 -33.15 -3.74 -7.35 -49.16

Phaarmasia Share Price

113.80 1.80 (1.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×